All News
Filter News
Found 808,541 articles
-
Federal Trade Commission Provisionally Accepts Consent Decree and Terminates Waiting Period for King Pharmaceuticals®, Inc.’s Acquisition of Alpharma Inc.
12/29/2008
-
Cytokinetics, Inc. Retains Development and Commercialization Rights to Ispinesib and SB-743921
12/29/2008
-
ProteLight and BioAMPs Take on Antibiotic-Resistant Bacteria
12/29/2008
-
Urigen Pharmaceuticals, Inc. Amends Its Core University of California, San Diego (UCSD) License for URG101
12/29/2008
-
Cytokinetics, Inc. Retains Development and Commercialization Rights to Ispinesib and SB-743921
12/29/2008
-
Breckenridge Pharmaceutical, Inc. Enters Agreement With Helm AG to Develop Third ANDA Project
12/29/2008
-
SemBioSys Genetics Inc. Receives US $2.5 Million in Option Agreement with MannKind Biopharmaceuticals for Plant-Produced Insuli
12/29/2008
-
Ariadne Genomics, Inc. Provides Pathway Studio(R) Interoperability with Illumina, Inc.’s New GenomeStudio Software
12/29/2008
-
Accuray Inc. Reaches 100th U.S. CyberKnife System Installation
12/29/2008
-
Heart Health, Inc. Makes Significant Progress in the Development and Production of the Heart Health Monitor in 2008
12/29/2008
-
Northwest Biotherapeutics Secures US$0.5 Million Debt Financing
12/29/2008
-
Medipattern™ Corporation Closes Convertible Debenture Financing
12/29/2008
-
Insmed Incorporated Announces that NASDAQ Extends Temporary Suspension of Minimum Bid Closing Price Rule
12/29/2008
-
Interleukin Genetics Inc. Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
12/29/2008
-
Synvista Therapeutics Notified by NYSE Alternext of Continued Listing Standards Non-Compliance
12/29/2008
-
VirtualScopics, LLC Receives Further Extension to Regain Compliance with Nasdaq
12/29/2008
-
Stereotaxis, Inc. to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants
12/29/2008
-
American Scientific Resources Inc. Announces Outcome of Annual Meeting of Shareholders
12/29/2008
-
Peregrine Pharmaceuticals, Inc. Receives Notification of Extension to Regain Compliance With NASDAQ's Minimum Bid Price Rule
12/29/2008
-
Trimeris, Inc. Receives NASDAQ Audit Committee Deficiency Notification
12/29/2008